A Genomic- and Proteomic-Based Hypothesis on the Eclectic Effects of Systemic Interleukin-2 Administration in the Context of Melanoma-Specific Immunization

Publisher： Karger

E-ISSN： 1422-6421|177|3|124-131

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.177, Iss.3, 2004-09, pp. : 124-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteomic-Based Biomarker Discovery with Emphasis on Cerebrospinal Fluid and Multiple Sclerosis

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 3, 2006-06 ,pp. : 147-158

Bentham Science Publishers

Access to resources Recommend Favorite

High-Throughput Proteomic-Based Identification of Oxidatively Induced Protein Carbonylation in Mouse Brain

By Soreghan Brian A.   Yang Frank   Thomas Stefani N.   Hsu Jennifer   Yang Austin J.  

Pharmaceutical Research, Vol. 20, Iss. 11, 2003-11 ,pp. : 1713-1720

Springer Publishing Company

Access to resources Recommend Favorite

Proteomic-based Analysis for Identification of Proteins Involved in 5-fluorouracil Resistance in Hepatocellular Carcinoma

By  

Current Pharmaceutical Design, Vol. 20, Iss. 1, 2014-01 ,pp. : 81-87

Bentham Science Publishers

Access to resources Recommend Favorite

Alternating chemo-immunotherapy with temozolomide and interleukin-2 in the treatment of metastatic melanoma

By  

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Carbon anhydrase IX specific immune responses in patients with metastatic renal cell carcinoma potentially cured by interleukin-2 based immunotherapy

By Rasmussen Susanne   Donskov Frede   Pedersen Johannes W.   Wandall Hans H.   Buus Søren   Harndahl Mikkel   Braendstrup Peter   Claesson Mogens H.   Pedersen Anders Elm  

Immunopharmacology and Immunotoxicology, Vol. 35, Iss. 4, 2013-08 ,pp. : 487-496

Informa Healthcare

Access to resources Recommend Favorite